T1	DISO 182 188	cáncer
#1	AnnotatorNotes T1	C0006826; Malignant Neoplasms; Neoplastic Process
T2	PROC 78 89	tratamiento
#2	AnnotatorNotes T2	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T3	PROC 103 123	análisis de biopsias
T4	PROC 490 514	Consentimiento informado
#3	AnnotatorNotes T4	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T5	ANAT 136 142	tejido
#4	AnnotatorNotes T5	C0040300; Body tissue; Tissue | C1284837; Entire body tissue; Tissue
T6	ANAT 150 164	tejido tumoral
T7	DISO 364 370	cáncer
#5	AnnotatorNotes T7	C0006826; Malignant Neoplasms; Neoplastic Process
T8	PROC 285 305	análisis de biopsias
T9	ANAT 318 324	tejido
#6	AnnotatorNotes T9	C0040300; Body tissue; Tissue | C1284837; Entire body tissue; Tissue
T10	ANAT 332 346	tejido tumoral
T11	DISO 402 408	Cáncer
#7	AnnotatorNotes T11	C0006826; Malignant Neoplasms; Neoplastic Process
T12	DISO 443 461	Cáncer metastásico
T13	DISO 547 565	cáncer metastásico
T14	ANAT 594 600	tejido
#8	AnnotatorNotes T14	C0040300; Body tissue; Tissue | C1284837; Entire body tissue; Tissue
T15	DISO 701 711	enfermedad
#9	AnnotatorNotes T15	C0012634; Disease; Disease or Syndrome
T16	PROC 754 761	biopsia
#10	AnnotatorNotes T16	C0005558; Biopsy; Diagnostic Procedure
T17	PROC 764 787	intervención quirúrgica
#11	AnnotatorNotes T17	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T18	PROC 801 817	biopsia de tumor
T19	DISO 962 980	Enfermedad medible
#12	AnnotatorNotes T19	C1513041; Measurable Disease; Disease or Syndrome
T20	DISO 1042 1089	Alteración de función orgánica o hematopoyética
T21	DISO 1224 1243	metástasis hepática
#13	AnnotatorNotes T21	C0494165; Secondary malignant neoplasm of liver; Neoplastic Process
T22	DISO 1341 1357	síndrome Gilbert
T23	PROC 1360 1371	Neutrófilos
#14	AnnotatorNotes T23	C0200633; Neutrophil count; Laboratory Procedure
T24	PROC 1403 1412	Plaquetas
#15	AnnotatorNotes T24	C0032181; Platelet Count measurement; Laboratory Procedure
T25	PROC 1478 1486	Calcemia
#16	AnnotatorNotes T25	C0729820; Blood calcium measurement; Laboratory Procedure
T26	PROC 1499 1509	Fosfatemia
#17	AnnotatorNotes T26	C0853250; Blood phosphate; Laboratory Procedure
T27	PROC 1566 1573	biopsia
#18	AnnotatorNotes T27	C0005558; Biopsy; Diagnostic Procedure
T28	DISO 1574 1616	Metástasis cerebral o meníngea sintomática
T29	ANAT 1596 1604	meníngea
#19	AnnotatorNotes T29	C1285087; Entire meninges; Body Part, Organ, or Organ Component
T30	PROC 1685 1706	terapia personalizada
T31	DISO 1717 1735	anomalía molecular
T32	PROC 1758 1769	tratamiento
#20	AnnotatorNotes T32	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T33	PROC 1795 1815	tratamiento dirigido
#21	AnnotatorNotes T33	C2985566; Targeted Therapy; Therapeutic or Preventive Procedure
T34	PROC 1849 1865	terapia hormonal
#22	AnnotatorNotes T34	C0279025; Hormone Therapy; Therapeutic or Preventive Procedure
T35	PROC 1893 1900	terapia
#23	AnnotatorNotes T35	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T36	PROC 1945 1952	terapia
#24	AnnotatorNotes T36	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T37	PROC 1971 1991	tratamiento dirigido
#25	AnnotatorNotes T37	C2985566; Targeted Therapy; Therapeutic or Preventive Procedure
T38	PROC 2147 2167	tratamiento dirigido
#26	AnnotatorNotes T38	C2985566; Targeted Therapy; Therapeutic or Preventive Procedure
T39	ANAT 115 123	biopsias
#27	AnnotatorNotes T39	C0677862; Biopsy sample; Tissue
T40	DISO 157 164	tumoral
#28	AnnotatorNotes T40	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T41	ANAT 297 305	biopsias
#29	AnnotatorNotes T41	C0677862; Biopsy sample; Tissue
T42	DISO 339 346	tumoral
#30	AnnotatorNotes T42	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T43	PROC 678 685	régimen
#31	AnnotatorNotes T43	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T44	DISO 812 817	tumor
#32	AnnotatorNotes T44	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T45	PROC 1133 1136	AST
#33	AnnotatorNotes T45	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
T46	PROC 1139 1142	ALT
#34	AnnotatorNotes T46	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T47	ANAT 1235 1243	hepática
#35	AnnotatorNotes T47	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T48	PROC 1260 1263	AST
#36	AnnotatorNotes T48	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
T49	PROC 1266 1269	ALT
#37	AnnotatorNotes T49	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T50	PROC 1307 1318	Bilirrubina
#38	AnnotatorNotes T50	C0863174; Blood bilirubin measurement; Laboratory Procedure
T51	PROC 1431 1442	Hemoglobina
#39	AnnotatorNotes T51	C0518015; Hemoglobin measurement; Laboratory Procedure
T52	PROC 1455 1465	Creatinina
#40	AnnotatorNotes T52	C0201975; Creatinine measurement; Laboratory Procedure
T53	DISO 1520 1549	Anormalidad de la coagulación
T54	ANAT 1585 1593	cerebral
#41	AnnotatorNotes T54	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T55	PROC 1644 1655	radioimagen
T56	CHEM 1857 1865	hormonal
#42	AnnotatorNotes T56	C0019932; Hormones; Hormone
T57	Date 12 16	2013
T58	LIVB 168 177	pacientes
#43	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group
T59	LIVB 350 359	pacientes
#44	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T61	LIVB 633 642	Pacientes
#45	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group
T62	Age 866 885	a partir de 18 años
T63	Duration 909 929	por lo menos 3 meses
T65	Neg_cue 1197 1204	excepto
T66	LIVB 1210 1219	pacientes
#46	AnnotatorNotes T66	C0030705; Patients; Patient or Disabled Group
T68	PHYS 1538 1549	coagulación
#47	AnnotatorNotes T68	C0005778; Blood coagulation; Organ or Tissue Function
T69	LIVB 1656 1665	Pacientes
#48	AnnotatorNotes T69	C0030705; Patients; Patient or Disabled Group
T72	Spec_cue 1938 1940	si
T60	PHYS 1056 1089	función orgánica o hematopoyética
#49	AnnotatorNotes T60	C1254358; Organ or Tissue Function; Organ or Tissue Function | C0018951; Hematopoiesis; Organ or Tissue Function
T67	LIVB 2034 2036	IP
#50	AnnotatorNotes T67	C1521895; Principal Investigator; Professional or Occupational Group
T64	PROC 932 950	Performance status
#51	AnnotatorNotes T64	C4525818; Clinical Performance Status; Health Care Activity | C3694602; functional status of patient; Therapeutic or Preventive Procedure
T70	PROC 586 612	obtener tejido histológico
#52	AnnotatorNotes T70	C0344441; Histology Procedure; Laboratory Procedure
A1	Assertion T66 Negated
A2	Assertion T21 Negated
A3	Assertion T37 Speculated
A4	Assertion T36 Speculated
A5	Assertion T27 Contraindicated
A6	Status T43 History_of
A7	Status T30 History_of
A8	Status T32 History_of
#53	AnnotatorNotes T6	C0475358; Tumor tissue sample; Tissue
#54	AnnotatorNotes T10	C0475358; Tumor tissue sample; Tissue
#55	AnnotatorNotes T12	C2939420; Metastatic Neoplasm; Neoplastic Process
#56	AnnotatorNotes T13	C2939420; Metastatic Neoplasm; Neoplastic Process
#57	AnnotatorNotes T22	C0017551; Gilbert Disease (disorder); Disease or Syndrome 
#58	AnnotatorNotes T53	C1846821; Abnormality of coagulation; Finding
#59	AnnotatorNotes T55	C1962945; Radiographic imaging procedure; Diagnostic Procedure
R1	Negation Arg1:T65 Arg2:T66	
R2	Negation Arg1:T65 Arg2:T21	
R3	Experiences Arg1:T66 Arg2:T21	
R4	Speculation Arg1:T72 Arg2:T36	
R5	Speculation Arg1:T72 Arg2:T37	
T71	Spec_cue 2107 2114	debería
T73	CONC 2096 2106	resolución
A9	Assertion T73 Speculated
#60	AnnotatorNotes T73	C2699488; Resolution; Conceptual Entity
R6	Speculation Arg1:T71 Arg2:T73	
R7	Before Arg1:T73 Arg2:T38	
T74	Quantifier_or_Qualifier 124 132	pareadas
R8	Has_Quantifier_or_Qualifier Arg1:T39 Arg2:T74	
R9	Location_of Arg1:T5 Arg2:T3	
R10	Location_of Arg1:T39 Arg2:T3	
R11	Location_of Arg1:T6 Arg2:T3	
T75	Quantifier_or_Qualifier 143 147	sano
#61	AnnotatorNotes T75	C3898900; Healthy; Qualitative Concept
R13	Has_Quantifier_or_Qualifier Arg1:T5 Arg2:T75	
R14	Experiences Arg1:T58 Arg2:T2	
R15	Experiences Arg1:T58 Arg2:T3	
R16	Experiences Arg1:T58 Arg2:T40	
R17	Experiences Arg1:T58 Arg2:T1	
T76	Quantifier_or_Qualifier 189 197	avanzado
#62	AnnotatorNotes T76	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R18	Has_Quantifier_or_Qualifier Arg1:T1 Arg2:T76	
R19	Location_of Arg1:T41 Arg2:T8	
T77	Quantifier_or_Qualifier 306 314	pareadas
R20	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T77	
R21	Location_of Arg1:T9 Arg2:T8	
R22	Location_of Arg1:T10 Arg2:T8	
T78	Quantifier_or_Qualifier 325 329	sano
#63	AnnotatorNotes T78	C3898900; Healthy; Qualitative Concept
R24	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T78	
R25	Experiences Arg1:T59 Arg2:T8	
R26	Experiences Arg1:T59 Arg2:T42	
R27	Experiences Arg1:T59 Arg2:T7	
T79	Quantifier_or_Qualifier 371 379	avanzado
#64	AnnotatorNotes T79	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R28	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T79	
T80	Quantifier_or_Qualifier 409 417	avanzado
#65	AnnotatorNotes T80	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R29	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T80	
R30	Location_of Arg1:T14 Arg2:T70	
T81	Result_or_Value 622 628	normal
#66	AnnotatorNotes T81	C0459422; Normal result; Finding | C0586624; Normal laboratory finding; Finding
T82	Quantifier_or_Qualifier 613 621	homólogo
R23	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T82	
R32	Has_Result_or_Value Arg1:T14 Arg2:T81	
T83	Quantifier_or_Qualifier 662 677	por lo menos un
R12	Has_Quantifier_or_Qualifier Arg1:T43 Arg2:T83	
R33	Experiences Arg1:T61 Arg2:T43	
R34	Experiences Arg1:T61 Arg2:T15	
T84	Quantifier_or_Qualifier 712 720	avanzada
#67	AnnotatorNotes T84	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R35	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T84	
T85	Observation 723 732	Capacidad
#68	AnnotatorNotes T85	C1299581; Able (finding); Finding (?) | C1555472; Authorized; Finding (?)
R36	Overlap Arg1:T85 Arg2:T16	
R37	Overlap Arg1:T85 Arg2:T17	
R38	Before Arg1:T17 Arg2:T18	
R39	Overlap Arg1:T85 Arg2:T18	
T86	Quantifier_or_Qualifier 825 835	emparejado
R40	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T86	
T87	Quantifier_or_Qualifier 843 851	homólogo
T88	Result_or_Value 852 858	normal
#69	AnnotatorNotes T88	C1873497; Normal assessment finding; Finding
R41	Has_Quantifier_or_Qualifier Arg1:T44 Arg2:T86	
R42	Has_Quantifier_or_Qualifier Arg1:T44 Arg2:T87	
R43	Has_Result_or_Value Arg1:T44 Arg2:T88	
T89	Quantifier_or_Qualifier 818 824	fresco
#70	AnnotatorNotes T89	C0443224; Fresh (qualifier value); Qualitative Concept 
R44	Has_Quantifier_or_Qualifier Arg1:T44 Arg2:T89	
T90	CONC 888 905	Esperanza de vida
#71	AnnotatorNotes T90	C0023671; Life Expectancy; Group Attribute
R45	Has_Duration_or_Interval Arg1:T90 Arg2:T63	
T91	Result_or_Value 954 959	0 a 1
R46	Has_Result_or_Value Arg1:T64 Arg2:T91	
T92	CONC 999 1015	criterios RECIST
#72	AnnotatorNotes T92	C1709926; Response Evaluation Criteria in Solid Tumors; Intellectual Product
T93	Quantifier_or_Qualifier 983 992	evaluable
#73	AnnotatorNotes T93	C5575332; Evaluable; Qualitative Concept
T94	Result_or_Value 1143 1196	> 2,5 veces el límite superior de la normalidad (LSN)
R49	Has_Result_or_Value Arg1:T45 Arg2:T94	
R50	Has_Result_or_Value Arg1:T46 Arg2:T94	
R51	Location_of Arg1:T47 Arg2:T21	
T95	Result_or_Value 1270 1275	> 5.0
R54	Has_Result_or_Value Arg1:T48 Arg2:T95	
R55	Has_Result_or_Value Arg1:T49 Arg2:T95	
T96	Result_or_Value 1319 1326	> 2 LSN
R56	Has_Result_or_Value Arg1:T50 Arg2:T96	
T97	Result_or_Value 1386 1400	<1,5 x 109 / L
R57	Has_Result_or_Value Arg1:T23 Arg2:T97	
T98	Quantifier_or_Qualifier 1372 1385	polinucleares
R58	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T98	
T99	Result_or_Value 1413 1428	<100 x 10 9 / L
R59	Has_Result_or_Value Arg1:T24 Arg2:T99	
T100	Result_or_Value 1443 1452	<90 g / L
R60	Has_Result_or_Value Arg1:T51 Arg2:T100	
T101	Result_or_Value 1466 1475	> 1,5 LSN
R61	Has_Result_or_Value Arg1:T52 Arg2:T101	
T102	Result_or_Value 1487 1496	> 1.5 LSN
R62	Has_Result_or_Value Arg1:T25 Arg2:T102	
T103	Result_or_Value 1510 1519	> 1.5 LSN
R63	Has_Result_or_Value Arg1:T26 Arg2:T103	
R66	Location_of Arg1:T54 Arg2:T28	
R67	Location_of Arg1:T29 Arg2:T28	
T104	Quantifier_or_Qualifier 1619 1629	progresiva
#74	AnnotatorNotes T104	C0205329; Progressive; Functional Concept
R69	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T104	
R70	Experiences Arg1:T69 Arg2:T30	
R71	Experiences Arg1:T69 Arg2:T31	
R72	Overlap Arg1:T31 Arg2:T32	
#75	AnnotatorNotes T31	C1704257; Molecular Genetic Abnormality; Finding (?)
T105	CONC 1770 1784	inmediatamente
#76	AnnotatorNotes T105	C0205253; Immediate; Temporal Concept
R74	Overlap Arg1:T32 Arg2:T105	
R75	Before Arg1:T105 Arg2:T33	
R73	Experiences Arg1:T69 Arg2:T32	
R76	Experiences Arg1:T69 Arg2:T33	
R77	Used_for Arg1:T56 Arg2:T34	
R78	Overlap Arg1:T34 Arg2:T35	
R31	Experiences Arg1:T66 Arg2:T48	
R47	Experiences Arg1:T66 Arg2:T49	
#77	AnnotatorNotes T74	C1708943; Match; Qualitative Concept
#78	AnnotatorNotes T77	C1708943; Match; Qualitative Concept
A10	Experiencer T58 Patient
A11	Experiencer T59 Patient
A12	Experiencer T61 Patient
A13	Experiencer T66 Patient
A14	Experiencer T69 Patient
A15	Experiencer T67 Other
